Pure Global
NCT06319612

Effectiveness of Stellate Ganglion Block for the Treatment of Obstructive Sleep Apnea

Effectiveness of Stellate Ganglion Block for the Treatment of Obstructive Sleep Apnea: A Randomized Controlled Trial
Copka Sonpashan·ClinicalTrials.gov·behavioralNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Obstructive Sleep Apnea
Drug/Device/Intervention
routine rehabilitation treatment
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Copka Sonpashan
Funder
Chao Phya Abhaibhubejhr Hospital
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2024
End date
Dec 01, 2024
Enrollment
80 participants
Primary outcome

Epworth Sleepiness Scale

Summary

The goal of this clinical trial is to test the efficacy of stellate ganglion block in
 Obstructive Sleep Apnea. The main question it aims to answer are:
 
 • Can stellate ganglion block improve Obstructive Sleep Apnea? Patients were randomly divided
 into two groups, all provided with routine therapy. Based on this, the experimental group was
 given stellate ganglion block. The video fluoroscopic swallowing study was done to test the
 swallowing function before and after the study.

ICD-10 classifications
Sleep apnoeaSleep disordersSleep disorder, unspecifiedPrimary sleep apnoea of newbornNonorganic sleep disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06319612
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06319612 through Pure Global AI's free database. This phase not specified trial is sponsored by Copka Sonpashan and is currently Not yet recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.